Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
- PMID: 35746498
- PMCID: PMC9230923
- DOI: 10.3390/vaccines10060891
Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
Abstract
Until December 2019, we were living in the world of successfully functioning vaccines and vaccination programs [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
[BCG vaccines for the prevention of tuberculosis in the world].Kekkaku. 1997 Nov;72(11):629-37. Kekkaku. 1997. PMID: 9423301 Japanese.
-
Vaccinology in practical perspective.Dev Biol Stand. 1986;63:5-13. Dev Biol Stand. 1986. PMID: 3527820
-
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271. Eur Rev Med Pharmacol Sci. 2021. PMID: 34859883
-
Advances in Vaccines.Adv Biochem Eng Biotechnol. 2020;171:155-188. doi: 10.1007/10_2019_107. Adv Biochem Eng Biotechnol. 2020. PMID: 31446443 Free PMC article. Review.
-
Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations.Expert Rev Vaccines. 2019 Jun;18(6):587-596. doi: 10.1080/14760584.2019.1607303. Epub 2019 Apr 30. Expert Rev Vaccines. 2019. PMID: 30998430 Review.
Cited by
-
Challenges and Opportunities in the Process Development of Chimeric Vaccines.Vaccines (Basel). 2023 Dec 8;11(12):1828. doi: 10.3390/vaccines11121828. Vaccines (Basel). 2023. PMID: 38140232 Free PMC article. Review.
-
Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines.Vaccines (Basel). 2025 Feb 15;13(2):191. doi: 10.3390/vaccines13020191. Vaccines (Basel). 2025. PMID: 40006737 Free PMC article. Review.
References
-
- Carrat F., Fontaine H., Dorival C., Simony M., Diallo A., Hezode C., De Ledinghen V., Larrey D., Haour G. French ANRS CO22 Hepather cohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: A prospective cohort study. Lancet. 2019;393:1453–1464. doi: 10.1016/S0140-6736(18)32111-1. - DOI - PubMed
-
- Trickey A., May M.T., Vehreschild J., Obel N., Gill M.J., Crane H.M., Boesecke C., Patterson S., Grabar S., Cazanave C., et al. Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. Lancet HIV. 2017;4:e349–e356. doi: 10.1016/S2352-3018(17)30066-8. - DOI - PMC - PubMed
-
- Marcus J.L., Leyden W.A., Alexeeff S.E., Anderson A.N., Hechter R.C., Hu H., Lam J.O., Towner W.J., Yuan Q., Horberg M.A., et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016. JAMA Netw. Open. 2020;3:e207954. doi: 10.1001/jamanetworkopen.2020.7954. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources